Home › Type 2 Diabetes › Connecticut
Pag-aaral pangklinika para sa Type 2 Diabetes sa Connecticut
14 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa Connecticut.
Mga Lungsod sa Connecticut
Opisyal na teksto ng pag-aaral (English)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
- Cardiology Associates of Fairfield County, Stamford
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07064473Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Chase Medical Research LLC, Waterbury
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07817251A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Yale University, New Haven
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07271186A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Yale School of Medicine, New Haven
Nagre-recruitPhase 3
Edad 10 hanggang 18 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07282613A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bridgeport
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07662213A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Bridgeport
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Yale Diabetes Research, New Haven
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Yale, New Haven
Nagre-recruit
Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT07376655Ultrasound Effects on Glycemic Control in T2DM
- Yale-New Haven Hospital, New Haven
Nagre-recruit
Edad 21 hanggang 75 · Lahat ng kasarian · Na-update Ene 27, 2026 · NCT05354947Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
- Fair Haven Community Health Care (FHCHC), New Haven
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 3, 2025 · NCT06658067Diabetes Learning in Virtual Environments Just in Time for Community Reentry
- University of Connecticut, Storrs
- University of Connecticut, Storrs Mansfield
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2025 · NCT05286892Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
- Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ene 14, 2025 · NCT05776563Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.